Western Ontario and McMaster University Osteoarthritis Index. A score derived from a questionnaire in which the patient answers questions regarding rheumatic symptoms, stiffness, pain and how it affects the ability to function
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.
References in periodicals archive ?
As early as 4 weeks into the study, the physical therapy group showed significantly greater improvement than in the comparison arm: from a mean baseline WOMAC score of 115 to 42.9 at 4 weeks, 42.5 at 6 months, and 38.4 at 1 year.
Significant improvement in VAS, SF-36, WOMAC score, hyperemia, and thickness of suprapatellar recess synovium from baseline was seen up to 6 months after intra-articular HA injection.
All three trials reported reductions in pain and stiffness, as well as improvements to function and the overall WOMAC score. All three studies showed improvements with Pycnogenol compared to placebo, but the third study was the most significant in results with scores for pain, stiffness and physical function dropping by nearly 50%.
A total WOMAC score is calculated by adding together the items for all three subscales, giving a maximum total mark of 2400.
The WOMAC score (Western Ontario and McMaster Universities Arthritis Index) [10] on presentation was 91; the EQ-5D-5L Index (European Quality of Life Five-Dimension Five-Level Scale) [11] was 0.048.
The primary outcome measure was the need for surgical intervention at 12 months while their WOMAC score (WOMAC 3.1[R]; http://www.womac.org) was the secondary outcome measure and was recorded preoperatively as well as at one-, six-, and 12-month follow-up.
Preoperative WOMAC score (SD) 6.26 (0.27) Primary 6.4 (0.37) Revision 6.13 (0.40) Oxford Knee Score (SD) 15 (1) Primary 15 (2) Revision 15 (2) KSS clinical (SD) 25 (3) Primary 15 (3) Revision 35 (4) KSS function (SD) 25 (3) Primary 23 (4) Revision 28 (4) ROM (SD) 72 (5) Primary 85 (4) Revision 60 (8) 5-year postoperative p value WOMAC score (SD) 2.45 (0.29) p < 0.001 Primary 2.04 (0.38) Revision 2.84 (0.42) Oxford Knee Score (SD) 31 (1) p < 0.001 Primary 34 (2) Revision 29 (2) KSS clinical (SD) 89 (2) p < 0.001 Primary 92 (4) Revision 87 (3) KSS function (SD) 58 (4) p < 0.001 Primary 60 (6) Revision 56 (5) ROM (SD) 115 (2) p < 0.001 Primary 116 (3) Revision 114 (3)
The term “clinically controlled” refers to a WOMAC score ≥75%; “significantly improved” indicates a WOMAC score ≥50%, but <75%; “improved” suggests a WOMAC score ≥25%, but <50%; and “ineffective” referred to a WOMAC score <25%.
2: The average of WOMAC index score before and after treatment in both groups WOMAC Score Index After treatment 30 Group B After Treatment 41 Group A Pre treatment 74 Note: Table made from bar graph.
The WOMAC score for osteoarthritis hip was used to assess the functional results, the WOMAC score 80 (Range: 37-100).
At baseline, the average WOMAC score was 100.8--but after two years, participants receiving exercise therapy in addition to their usual care improved by 31.7 WOMAC points compared to usual care alone.
The regression model revealed that the variable exhibiting the most significant effect of improvement on KSS and WOMAC score was balanced joint state (P = 0.001; P = 0.014).